KODA Therapeutics
Pharmaceutical Manufacturing • 
Brockton, Massachusetts, United States • 1-10 Employees
Company overview
| Headquarters | 321 Manley St, West Bridgewater, Massachusetts 02379, US |
| NAICS | 3254 |
| Keywords | Research, Discovery, Development, Aanti Infective, Gram Negative |
| Founded | 2021 |
| Employees | 1-10 |
Key Contact at KODA Therapeutics
Joseph St Laurent
President, CSO
About KODA Therapeutics
KODA Therapeutics is a small molecule pharmaceutical development company specializing in the discovery, research, and development of novel antibacterial agents for the treatment of gastro-intestinal diseases caused by gram-negative and gram-positive bacteria.
$
KODA Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Funding Data
KODA Therapeutics has never raised funding before.
Australia
SpainFrequently asked questions
KODA Therapeutics is located in Brockton, Massachusetts, US.
KODA Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.
KODA Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
